Ohio Lawmakers Study Psychedelic Drug Ibogaine for PTSD, Addiction Treatment
Ohio Republicans explore joining multistate research into ibogaine, a psychedelic drug showing promise for treating PTSD and opioid addiction among veterans.
COLUMBUS, OHIO — Republican lawmakers in Ohio are considering joining a multistate research effort to study ibogaine, a psychedelic drug that shows promise for treating post-traumatic stress disorder and opioid addiction.
The effort represents a shift for a party that previously championed aggressive drug war policies. State Rep. Justin Pizzulli, R-Scioto County, chairs the Ibogaine Treatment Study Committee and successfully lobbied for its creation as part of last year’s budget.
“I think that, looking at the effect it has on veterans, and just hearing people talk about how it helped them — it stopped them from committing suicide — I think that’s a message that Republicans are very passionate about,” Pizzulli said.
Portsmouth’s Opioid Crisis Connection
Pizzulli represents Portsmouth, which he described as “ground zero” for the opioid crisis in Ohio. The devastating impact on his community drives his commitment to exploring alternative treatments.
“It was the greatest crisis to ever happen to my community in our lifetime, and we’re still paying and recovering for it,” Pizzulli said. “I made a promise to my constituency to be sure to find alternative methods to help fix and to research things that I think could potentially be helpful.”
National Research Collaboration
Several states are currently pooling funds to develop an ibogaine treatment that could gain FDA approval. The White House has endorsed the initiative and contributed $50 million to the research effort.
Initial studies suggest ibogaine rewires neural pathways in the brain and promotes regeneration. Researchers have documented effectiveness in treating both opioid addiction and PTSD, with potential applications for other conditions still under investigation.
Supporters emphasize their focus remains strictly on clinical therapies in controlled medical settings, not recreational use. Veterans seeking psychedelic-assisted treatment abroad have largely prompted the legislative interest in these alternative therapies.
Cautious Legislative Approach
During committee testimony Wednesday, supporters encouraged Ohio to join the multistate research collaboration. However, some lawmakers expressed skepticism about the state’s financial role in funding the effort, even while remaining open to the treatment approach.
The committee continues evaluating whether Ohio should participate in the broader research initiative. The state’s decision could impact access to potential treatments for thousands of Ohio veterans and residents struggling with PTSD and addiction.
Pizzulli’s committee represents part of a broader national trend as Republican lawmakers increasingly consider evidence-based approaches to mental health and addiction treatment, marking a departure from traditional drug policy positions.
